Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

HOMA-PULSE: Assessment of Glucose Metabolism and Insulin Resistance as a Predictor of Pulsed Field Ablation Success in Atrial Fibrillation

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07551947
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:41:25.516153+00:00
Published At
2026-04-27T00:00:00+00:00
Record Updated At
2026-04-27
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Atrial Fibrillation", "Insulin Resistance", "Catheter Ablation", "Artificial Intelligence"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-04-27"
protocolSection.identificationModule.nctId
"NCT07551947"
protocolSection.identificationModule.officialTitle
"HOMA-PULSE: Assessment of Glucose Metabolism and Insulin Resistance as a Predictor of Pulsed Field Ablation Success in Atrial Fibrillation"
protocolSection.statusModule.overallStatus
"ENROLLING_BY_INVITATION"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Atrial Fibrillation (protocolSection.conditionsModule.conditions)
  • Insulin Resistance (protocolSection.conditionsModule.conditions)
  • Catheter Ablation (protocolSection.conditionsModule.conditions)
  • Artificial Intelligence (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.